Nicotinic receptors, smoking and schizophrenia

Restorative Neurology and Neuroscience

Volumn 12, Issue 2-3, 1998, Pages 195-201

  Leonard, Sherry ^a,b   Gault, Judith ^a   Adams, Catherine ^a   Breese, Charles R ^a   Rollins, Yvonne ^a   Adler, Lawrence E ^a   Olincy, Ann ^a   Freedman, Robert ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Auditory gating; Nicotine; Nicotinic receptor; Schizophrenia; Smoking

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ARTICLE; CHOLINERGIC SYSTEM; EVOKED AUDITORY RESPONSE; HUMAN; MULTIGENE FAMILY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; SMOKING;

EID: 0031816889     PISSN: 09226028     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Adler, L.E., Gerhardt, G.A., Franks, R., Baker, N., Nagamoto, H., Drebing, C. and Freedman, R., Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res., 31 (1990) 297-309.
2. Adler, L.E., Hoffer, L.D., Wiser, A. and Freedman, R., Normalization of auditory physiology by cigarette smoking in schizophrenic patients, Am.J.Psych., 150 (1993) 1856-1861.
3. Adler, L.E., Koffer, L.J., Griffith, J., Waldo, M.C. and Freedman, R., Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics, Biol.Psych., 32 (1992) 607-616.
4. Adler, L.E., Pachtman, E., Franks, R., Pecevich, M., Waldo, M.C. and Freedman, R., Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia., Biol.Psychiatry, 17 (1982) 639-654.
5. Andreasen, N.C., Positive vs. negative schizophrenia: a critical evaluation., Schizophrenia Bulletin, 11 (1985) 380-389.
6. Anonymous, Additional support for schizophenia linkage on chromosomes 6 and 8: a multicenter study., Am.J.Med.Genet., 67 (1996) 580-594.
7. Benowitz, N.L., Pharmacology of nicotine: addiction and therapeutics., Annu.Rev.Pharmacol.Toxicol., 36 (1997) 597-613.
8. Bickford-Wimer, P.C., Nagamoto, H., Johnson, R., Adler, L., Egan, M., Rose, G.M. and Freedman, R., Auditory sensory gating in hippocampal neurons: a model system in the rat., Biol.Psychiatry, 27 (1990) 183-192.
9. Boutros, N.N., Zouridakis, G. and Overall, J., Replication and extension of P50 findings in schizophrenia, Clin.Electroencephalography, 22 (1991) 40-45.
10. Braff, D.L., Grillon, C. and Geyer, M.A., Gating and habituation of the startle reflex in schizophrenic patients., Arch.Gen.Psychiatry, 49 (1992) 206-215.
11. Braff, D.L. and Saccuzzo, D.P., The time course of information-processing deficits in schizophrenia.. Am J.Psychiatry, 142 (1985) 170-174.
12. 125I]-α-bungarotoxin binding in human postmortem brain., J.Comp.Neuro., 387 (1997) 385-398.
13. 3H]nicotine binding in human postmortem brain., J.Pharm.Ex.Ther., 282 (1997) 7-13.
14. Cloninger, C.R., Turning point in the design of linkage studies of schizophrenia., Am.J.Med.Gen.: Neuropsychiatric Gen, 54 (1994) 83-92.
15. Collins, F.S., Riordan, J.R. and Tsui, L.-C., The cystic fibrosis gene: isolation and significance, Hosp.Pract., 27 (1990) 133-137.
16. Crick, F., Function of the thalamic reticular complex: the searchlight hypothesis., Proc.Natl.Acad.Sci, 81 (1984) 4586-4590.
17. Freedman, R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Cullum, C.M., Griffith, J.M., Harris, J.G., Leonard, S., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rose, G. and Waldo, M.C., Schizophrenia and nicotinic receptors, Harvard Review of Psychiatry, 2 (1994) 179-192.
18. Freedman, R., Adler, L.E., Waldo, M.C., Pachtman, E. and Franks, R.D., Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients, Biol.Psychiatry, 18 (1983) 537-551.
19. Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M.C., Reimherr, R., Wender, P., Yaw, J., Young, D.A., Breese, C.R., Adams, C., Patterson, D., Adler, L.E., Kruglyak, L., Leonard, S. and Byerley, W., Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus., Proc.Natl.Acad.Sci., 94 (1996) 587-592.
20. Freedman, R., Hall, M., Adler, L.E. and Leonard, S., Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia., Biol.Psychiatry, 38 (1995) 22-33.
21. Freedman, R., Waldo, M., Bickford-Wimer, P. and Nagamoto, H., Elementary neuronal dysfunctions in schizophrenia, Schiz-Res., 4 (1991) 233-243.
22. Freedman, R., Wetmore, C., Strömberg, I., Leonard, S. and Olson, L., α-Bungarotoxin binding to hippocampal interneurons: Immunocytochemical characterization and effects on growth factor expression, J.Neurosci., 13 (1993) 1965-1975.
23. Gattaz, W.F., Schmitt, A. and Maras, A., Increased platelet phospholipase A2 activity in schizophrenia., Schiz.Res., 16 (1995) 1-6.
24. Gill, M., Vallada, H., Collier, D., Sham, P., Holmans, P., Murray, R., McGuffin, P., Nanko, S., Owen, M., Antonarakis, S., Housman, D., Kazazian, H., Nestadt, G., Pulver, A.E., Straub, R.E., MacLean, C.J., Walsh, D., Kendler, K.S., DeLisi, L., Polymeropoulos, M., Coon, H., Byerley, W., Lofthouse, R., Gernshon, E. and Read, C.M. et al., A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12., Am.J.Med.Genet., 67 (1996) 40-45.
25. Glassman, A.H., Cigarette smoking: implications for psychiatric illness., Am.J.Psychiatry, 150 (1994) 546-553.
26. Goff, D.C., Henderson, D.C. and Amico, E., Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects, Am.J.Psychiatry, 149 (1992) 1189-1194.
27. Goff, W.R., Williamson, P.D., VanGilder, J.C., Allison, R. and Fisher, T.C., Neural origins of long latency evoked potentials recorded from the depth and from the cortical surface of the brain in man, Prog.Clin.Neurophysiol, 7 (1980) 126-145.
28. Greeman, M. and McClellan, T.A., Negative effects of a smoking ban on an inpatient psychiatry service, Hosp.Comm.Psychiatry, 42 (1991) 408-412.
29. Horrobin, D.F., Schizophrenia as a membrane lipid disorder which is expressed throughout the body, Prostaglandins Leukotrienes & Essential Fatty Acids, 55 (1996) 3-7.
30. Kirch, D.G., Where there's smoke... nicotine and psychiatric discorders, Biol.Psychiatry, 30 (1991) 107-108.
31. Kirch, D.G., Bigelow, L.B., Weinberger, D.R., Lawson, W.B. and Wyatt, R.J., Polydipsia and chronic hyponatremia in schizophrenic inpatients, J.Clin.Psychiatry, 46 (1985) 179-181.
32. Laugharne, J.D., Mellor, J.E. and Peet M., Fatty acids and schizophrenia, Lipids, 31 (1996) S163-165.
33. Leonard, S., Adams, C., Breese, C.R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Griffith, J.M., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rollins, Y., Stevens, K.E., Waldo, M. and Freedman, R., Nicotinic receptor function in schizophrenia, Schiz.Bull., 22 (1996) 431-445.
34. Leonard, S., Logel, J., Luthman, D., Casanova, M., Kirch, D. and Freedman, R., Biological stability of mRNA isolated from human postmortem brain collections, Biol.Psych., 33 (1993) 456-466.
35. Lozsádi, D.A., Organization of cortical afferents to the rostral, limbic sector of the rat thalamic reticular nucleus, J.Comp.Neurol., 341 (1994) 520-533.
36. Luntz-Leybman, V., Bickford, P.C. and Freedman, R., Cholinergic gating of response to auditory stimuli in rat hippocampus, Brain Res., 587 (1992) 130-136.
37. Marks, M.J., Stitzel, J.A. and Collins, A.C., Time course study of the effects of chronic nicotine infusion on drug response and brain receptors, J.Pharm.Exp.Ther., 235 (1985) 619-628.
38. McGlashan, T.H. and Fenton, W.S., The positive-negative distinction in schizophrenia: review of natural history validators, Arch.Gen.Psychiatry, 49 (1992) 63-72.
39. Meehl, P.E., Schizotaxia, schizotypy, schizophrenia, Am.Psychologist, (1962) 827-838.
40. Menza, M.A., Grossman, N., VanHorn, C., Cody, R. and Forman, N., Smoking and movement disorders in psychiatric patients, Biol.Psychiatry, 30 (1991) 109-115.
41. Miller, C. and Freedman, R., Medial septal neuron activity in relation to an auditory sensory gating paradigm. Neuroscience, 55 (1993) 373-380.
42. Miner, L.L. and Collins, A.C., The effect of chronic nicotine treatment on nicotine-induced seizures, Psychopharmacology, 95 (1988) 52-55.
43. Mitrofanis, J. and Guillery, R.W., New views of the thalamic reticular nucleus in the adult and the developing brain., Trends Neurosci., 16 (1993) 240-245.
44. Nagamoto, H.T., Adler, L.E., Hea, R.A., Griffith, J.M., McRae, K.A. and Freedman, R., Gating of auditory P50 in schizophrenics: Unique effects of clozapine, Biol.Psych., 40 (1996) 181-188.
45. Olincy, A., Ross, R.G., Young, D.A., Roath, M. and Freedman, R., Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients., Neuropsychopharmacalogy, 18 (1998) 175-185.
46. Reite, M., Teale, P., Zimmerman, J.E., Davis, K. and Whalen, J., Source location of a 50 msec latency auditory evoked field component, Electroencephalog.Clin.Neurophysiol., 70 (1988) 490-498.
47. Reite, M., Teals, P., Zimmerman, J.E., Davis, K., Whalen, J. and Edrich, J., Source origin of a 50-msec latency auditory evoked field component in young schizophrenic men, Biol.Psychiatry, 24 (1988) 495-506.
48. Rollins, Y., Breese, C., Adams, C., Drebing, C., Rose, G.M. and Leonard, S., Cellular localization of α-bungarotoxin binding and α7 mRNA in the hippocampus related to auditory gating in the awake-behaving rat., Soc.Neurosci.Abst., 22 (1996) 1272
49. Rollins, Y.D., Stevens, K.E., Harris, K.R., Hall, M.E., Rose, G.M. and Leonard, S., Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α7 antisense oligonucleotides, Soc.Neurosci.Abst., 19 (1993) 837-837.
50. Ross, B.M., Hudson, C. Erlich, J., Warsh, J.J. and Kish, S.J., Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phopholipase A2., Arch. Gen. Psych., 54 (1997) 487-494.
51. Stevens, K.E., Freedman, R., Collins, A.C., Hall, M., Leonard, S., Marks, M.J. and Rose, G.M., Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains., Brain Res., 15 (1996) 152-162.
52. Stevens, K.E., Kem, W.R., Mahnir, V.M. and Freedman, R., Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice., Psychopharmacology, In Press (1998).
53. Stevens, K.E., Meltzer, J. and Rose, G.M., Nicotinic cholinergic normalization of amphetamine-induced loss of auditory gating in freely moving rats, Psychopharmacology, 119 (1995) 163-170.
54. Straumanis, J.J., Shagass, C. and Romer, R.A., Influence of antipsychotic and antidepressant drugs on evoked potential correlates of psychosis., Biol.Psychiatry, 17 (1982) 1101-1122.
55. Tsuang, M.T., Genotypes, phenotypes, and the brain: A search for connections in schizophrenia., Brit.J.Psychiatry, 163 (1993) 299-307.
56. Turecki, G., Rouleau, G.A., Joober, R. and Morgan, K., Schizophrenia and chromosome 6p., Am.J.Med.Genet., 74 (1997) 195-198.
57. Venebles, P., Input dysfunction in schizophrenia, in: "Progress in Experimental Personality Research", B.A. Maher, (Ed), Academic Press, New York, (1964) 1-47.
58. Vijayaraghavan, S., Huang, B., Blumenthal, E.M. and Berg D.K., Arachidonic acid as a possible negative feedback inhibitor of nicotinic acetylcholine receptors on neurons., J.Neurosci., 15 (1995) 3679-3687.
59. Wilson, C.L., Babb, T.L., Halgren, E., Wand, M.L. and Crandall, P.H., Habituation of human limbic neuronal response to sensory stimulation., Exper.Neurol., 84 (1984) 74-97.
60. Wonnacott, S., α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain., J.Neurochem., 47 (1986) 1706-1712.
61. Zuo, J., Robbins, C., Baharloo, S., Cox, D.R. and Myers, R.M., Construction of cosmid contigs and high-resolution restriction mapping of the Huntington disease region of chromosome 4., Hum.Mol.Gen., 2 (1993) 7-889.